Diabetes, Obesity and Metabolism, 1462-8902

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study

    The SUMMIT consortium, Natali, A., Nesti, L., Venturi, E., Shore, A. C., Khan, F., Gooding, K., Gates, P. E., Looker, H. C., Dove, F., Isabel Goncalves, Margaretha Persson & Jan Nilsson, 2019 feb, I : Diabetes, Obesity and Metabolism. 21, 2, s. 412-416

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2018
  4. MicroRNAs in islet hormone secretion

    Jonathan L.S. Esguerra, Mototsugu Nagao, Jones K. Ofori, Anna Wendt & Lena Eliasson, 2018 sep 1, I : Diabetes, Obesity and Metabolism. 20, Suppl 2, s. 11-19

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  5. Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

    Bo Ahrén, Atkin, S. L., Charpentier, G., Warren, M. L., Wilding, J. P. H., Birch, S., Holst, A. G. & Leiter, L. A., 2018 sep 1, I : Diabetes, Obesity and Metabolism. 20, 9, s. 2210-2219 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Different glucagon effects during DPP-4 inhibition versus SGLT-2 inhibition in metformin-treated type 2 diabetes patients

    Alsalim, W., Margaretha Persson & Bo Ahrén, 2018 jul, I : Diabetes, Obesity and Metabolism. 20, 7, s. 1652-1658

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects

    Alsalim, W., Olga Göransson, Carr, R. D., Bizzotto, R., Tura, A., Pacini, G., Mari, A. & Bo Ahrén, 2018 apr, I : Diabetes, Obesity and Metabolism. 20, 4, s. 1080-1085

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2017
  9. Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial

    Yabe, D., Eto, T., Shiramoto, M., Irie, S., Murotani, K., Seino, Y., Kuwata, H., Kurose, T., Seino, S., Bo Ahrén & Seino, Y., 2017, I : Diabetes, Obesity and Metabolism. 19, 3, s. 442-447

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes

    Preiss, D., Dawed, A., Welsh, P., Heggie, A., Jones, A. G., Dekker, J., Robert Koivula, Hansen, T. H., Stewart, C., Holman, R. R., Paul W. Franks, Walker, M., Pearson, E. R. & Sattar, N., 2017, I : Diabetes, Obesity and Metabolism. 19, 3, s. 356-363

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2016
  12. Mixed meal diminishes glucose excursion compared to glucose by several adaptive mechanisms in man.

    Alsalim, W., Tura, A., Pacini, G., Omar, B., Bizzotto, R., Mari, A. & Bo Ahrén, 2016, I : Diabetes, Obesity and Metabolism. 18, 1, s. 24-33

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 4 5 6 Nästa